Therapeutic implications of the cancer stem cell hypothesis.

Therapeutic implications of the cancer stem cell hypothesis.
复制标题

DOI:
10.1016/j.semradonc.2008.11.002
复制
发表时间:
2009-04
影响因子:
3.5
通讯作者:
Clarke, Michael F.
Clarke, Michael F.
中科院分区:
医学2区
文献类型:
--
作者:
Diehn, Maximilian;Cho, Robert W.;Clarke, Michael F.

文献摘要

参考文献

被引文献

相似文献

越来越多的证据表明,癌症干细胞(CSC)的亚群驱动和维持许多类型的人类恶性肿瘤。这些发现对肿瘤治疗的开发和评估具有重要意义,并为患者结局的潜在收益提供了机会。CSC的存在要求仔细分析和比较正常组织干细胞和CSC,以确定两种细胞类型之间的差异。CSC靶向治疗的发展将面临许多潜在的障碍,包括正常干细胞毒性和获得治疗抗性,必须考虑这些障碍,以最大限度地提高此类治疗成功的机会。
A growing body of evidence indicates that subpopulations of cancer stem cells (CSC) drive and maintain many types of human malignancies. These findings have important implications for the development and evaluation of oncologic therapies and present opportunities for potential gains in patient outcome. The existence of CSC mandates careful analysis and comparison of normal tissue stem cells and CSC in order to identify differences between the two cell types. The development of CSC-targeted treatments will face a number of potential hurdles, including normal stem cell toxicity and the acquisition of treatment resistance, which must be considered in order to maximize the chance that such therapies will be successful.
DOI: 10.1186/bcr920
发表时间: 2004
期刊: Breast cancer research : BCR
影响因子: --
作者:
Dontu G;Jackson KW;McNicholas E;Kawamura MJ;Abdallah WM;Wicha MS
通讯作者: Wicha MS
DOI: 10.1182/blood-2004-10-4135
发表时间: 2005-06-01
期刊: BLOOD
影响因子: 20.3
作者:
Guzman, ML;Rossi, RM;Jordan, CT
通讯作者: Jordan, CT
DOI: 10.1016/j.ydbio.2003.09.003
发表时间: 2003-12-15
影响因子: 2.7
作者:
Easterday, MC;Dougherty, JD;Kornblum, HI
通讯作者: Kornblum, HI
DOI: 10.1073/pnas.0703478104
发表时间: 2007-06-12
影响因子: 11.1
作者:
Dalerba, Piero;Dylla, Scott J.;Clarke, Michael F.
通讯作者: Clarke, Michael F.
DOI: 10.1158/0008-5472.can-05-2018
发表时间: 2005-12-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Collins, AT;Berry, PA;Maitland, NJ
通讯作者: Maitland, NJ